NATCO
Live / Registered — Registered (as of 04 Jun 2024)
What this means for you
Registered since 04 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97920925
- Registration number
- 7405840
- Mark type
- Stylized text
- Filed
- 04 May 2023
- Published for opposition
- 19 Mar 2024
- Registered
- 04 Jun 2024
- Attorney of record
- Michael A. Marrero
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of nausea and vomiting caused by cancer chemotherapy, radiation therapy, or surgery, and containing ondansetron; Pharmaceutical preparations for the treatment of angina by sublingual administration, namely, nitroglycerin tablets
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development
Owner
- Natco Pharma USA LLC, Parsippany, NJ, US
- Natco Pharma USA LLC, Parsippany, NJ, US
- Natco Pharma USA LLC, Parsippany, NJ, US
Prosecution history
- 04 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 19 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Mar 2024 — PUBLISHED FOR OPPOSITION
- 28 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Feb 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Feb 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 09 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Jan 2024 — ASSIGNED TO EXAMINER
- 04 Jun 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 08 May 2023 — NEW APPLICATION ENTERED